The Tirzepatide Shortage in 2026: How to Get Access Safely

For patients relying on GLP-1 medications for weight management, the ongoing drug shortages have been a significant source of frustration. Brand-name medications, particularly those containing tirzepatide, have frequently appeared on the FDA's Drug Shortages list over the past few years due to unprecedented demand.

If you are struggling to fill your prescription at your local pharmacy in 2026, you are not alone. Here is what you need to know about the current state of the tirzepatide shortage and how compounded tirzepatide provides a safe, accessible, and legal alternative.

Understanding the FDA Drug Shortage List

The FDA maintains a database of medications that are currently in short supply in the United States. When a drug is officially listed as "in shortage," it means the manufacturer cannot meet the national demand.

For weight loss patients, this shortage means calling multiple pharmacies, waiting weeks or months for a refill, and experiencing interruptions in their treatment plan—which can halt weight loss progress and cause side effects to return when the medication is finally restarted.

How Compounding Pharmacies Bridge the Gap

When a medication is on the FDA's official Drug Shortages list, federal law allows state-licensed compounding pharmacies (known as 503A pharmacies) to prepare compounded versions of the drug.

This is a critical regulatory mechanism designed to ensure that patients do not go without necessary medical treatments during commercial supply chain failures.

Compounded tirzepatide is prepared by highly trained pharmacists using the exact same active pharmaceutical ingredient (tirzepatide base) found in the commercial products. By utilizing compounding pharmacies, telehealth platforms can provide patients with continuous, uninterrupted access to their prescribed treatment.

Is Compounded Tirzepatide Safe and Legal?

Yes. As long as the brand-name medication remains on the FDA shortage list, it is entirely legal for 503A pharmacies to compound tirzepatide.

However, safety and quality depend entirely on where the medication is compounded. The FDA has issued warnings about purchasing medications from unregulated sources, "research chemical" websites, or overseas pharmacies.

To ensure safety, you must use a provider that partners exclusively with state-licensed, FDA-registered 503A compounding pharmacies located within the United States. These facilities are subject to strict regulatory oversight, regular inspections, and stringent quality control standards, including rigorous testing for purity, potency, and sterility.

The Fig Approach to Reliable Access

At Fig, we understand that consistency is the key to successful weight management. Interruptions in your medication schedule can derail your progress. That is why we have built a supply chain designed for reliability.

Here is how Fig ensures you get safe access to compounded tirzepatide during the shortage:

1. US-Based, 503A Pharmacies: We partner exclusively with fully vetted, state-licensed compounding pharmacies in the United States. We never source ingredients from unverified international suppliers.

2. Physician Oversight: Every prescription is authorized by a licensed, board-certified physician who reviews your medical history to ensure tirzepatide is safe and appropriate for you.

3. Direct-to-Door Delivery: You never have to call around to local pharmacies to check stock. Your medication is compounded to order and shipped directly to your home in temperature-controlled packaging.

4. Transparent Pricing: During shortages, some clinics engage in price gouging. Fig maintains transparent, flat-rate pricing. Our compounded tirzepatide starts at $258/month (on a 6-month plan) with absolutely zero hidden membership fees.

What Happens When the Shortage Ends?

The FDA continuously monitors supply levels. Eventually, the manufacturer will increase production capacity enough to meet demand, and tirzepatide will be removed from the shortage list.

When a drug is removed from the shortage list, compounding pharmacies must generally cease producing copies of the commercially available drug. However, compounding is still permitted if a physician determines that a compounded version is necessary for a specific patient (for example, if the patient needs a specific dosage strength not commercially available, or is allergic to an inactive ingredient in the brand-name product).

Reputable telehealth providers closely monitor FDA regulations and adapt their services to ensure patients remain compliant and supported in their weight loss journeys, regardless of supply chain shifts.

Secure Your Access Today

You do not have to put your health goals on hold because of supply chain issues. Compounded tirzepatide offers a safe, effective, and accessible path forward.

Start your online evaluation with Fig today and, if approved, have your medication shipped directly to your door—ensuring your weight loss journey remains uninterrupted.

Medical Disclaimer: Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Fig does not guarantee weight loss results. Individual outcomes vary. Treatment is only prescribed when a licensed provider determines it is clinically appropriate.